Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Fish and Richardson
McKinsey
Boehringer Ingelheim
Farmers Insurance
Baxter
AstraZeneca
Federal Trade Commission

Generated: November 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018781

« Back to Dashboard

NDA 018781 describes HUMULIN N, which is a drug marketed by Lilly and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the HUMULIN N profile page.

The generic ingredient in HUMULIN N is insulin susp isophane recombinant human. There are forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the insulin susp isophane recombinant human profile page.
Summary for 018781
Tradename:HUMULIN N
Applicant:Lilly
Ingredient:insulin susp isophane recombinant human
Patents:1
Suppliers and Packaging for NDA: 018781
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HUMULIN N insulin susp isophane recombinant human INJECTABLE;INJECTION 018781 NDA Eli Lilly and Company 0002-0800 0002-0800-01 1 VIAL in 1 CARTON (0002-0800-01) > 10 mL in 1 VIAL
HUMULIN N insulin susp isophane recombinant human INJECTABLE;INJECTION 018781 NDA Eli Lilly and Company 0002-8315 0002-8315-01 1 VIAL in 1 CARTON (0002-8315-01) > 10 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:INJECTABLE;INJECTIONStrength100 UNITS/ML
Approval Date:Oct 28, 1982TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Aug 9, 2024Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Farmers Insurance
Covington
AstraZeneca
Dow
Julphar
Colorcon
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.